Table 2 Patients’ characteristics stratified by biochemical recurrence using PSA 0.2 ng/mL definition
BCR (-) (n = 150) | BCR (+)(n = 53) | Total (n = 203) | p value | |
|---|---|---|---|---|
D’Amico risk classification | ||||
Low | 65 | 28 | 93 | |
Intermediate | 70 | 22 | 92 | |
High | 15 | 3 | 18 | 0.400* |
BED (Gy2) | ||||
Median (range) | 183.8 (136.4-244.0) | 171.8 (120.3-227.5) | 180.6 (120.3-244.0) | 0.009§ |
D90 (%) | ||||
Median (range) | 110.6 (90.0-136.9) | 108.6 (79.8-126.2) | 110.3 (79.8-136.9) | 0.106§ |
V100 (%) | ||||
Median (range) | 94.5 (85.5-99.5) | 93.9 (77.8-98.5) | 94.3 (77.8-99.5) | 0.124§ |
UD30 (%) | ||||
Median (range) | 139.2 (99.4-200.3) | 140.6 (104.2-197.9) | 139.2 (99.4-200.3) | 0.785§ |
R100 (mL) | ||||
Median (range) | 0.01 (0.0-1.19) | 0.04 (0.0-0.51) | 0.02 (0.0-1.19) | 0.207§ |